Search clinical trials for: Placebo (linagliptin)
Total 53868 results
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
JW PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Evidem Consultores SLBoehringer Ingelheim; Merck Serono International SA; European CommissionUnknown
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
University Hospital Inselspital, BerneFresenius KabiCompletedMalnourishment | Gastrointestinal TumorsSwitzerland
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
Merck Sharp & Dohme LLCCompleted
-
JW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
University of Colorado, DenverMerck Sharp & Dohme LLCCompletedCardiovascular Disease | Type 2 DiabetesUnited States
-
Boehringer IngelheimCompleted
-
Lundquist Institute for Biomedical Innovation at...Emmaus Medical, Inc.Terminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Eurofarma Laboratorios S.A.CompletedDiabetes Mellitus, Type 2Brazil
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
Dong Wha Pharmaceutical Co. Ltd.Completed
-
NeuroBo Pharmaceuticals Inc.RecruitingNON-ALCOHOLIC STEATOHEPATITISUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
Alexandria UniversityRecruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Lund UniversityCompleted
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Ukraine, Poland, Malaysia, Canada, Peru, Philippines, Hungary, Russian Federation, South Africa, Argentina, Croatia, Thailand
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Chronic Renal Insufficiency
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
Amsterdam UMC, location VUmcEU FP7: SAFEGUARD consortiumCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
The University of Texas Health Science Center at...Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan